益气养阴化瘀法治疗糖尿病肾病的用药策略
Herbal Administration Strategy for Tonifying Qi, Nourishing Yin and Dissolving Stasis Method for Treating Diabetic Nephropathy
摘要: 目的KDOQI糖尿病指南和慢性肾脏病指导下,结合中医对糖尿病和糖尿病肾病的病因病机的认识,旨在揭示益气养阴化瘀法治疗DN的用药规律与机理。方法:基于KDOQI的糖尿病和慢性肾脏病指南,选取益气养阴化瘀法治疗DN的文献,寻找有关药物对糖尿病和慢性肾脏病的用药规律与机理。结果与结论:气阴两虚,瘀血阻肾是DN基本病机,益气养阴化瘀法是治疗DN的基本治法。益气养阴化瘀法治疗DN的用药规律为:在益气、养阴、活血化瘀类中草药中注重选取降糖、降压、调脂、抗凝类的中药;同时注重选取护肾、抗肾脏纤维化类中药保护肾功能。益气养阴化瘀法治疗DN的中药药理机制为:降糖、降压、调脂、抗凝、阻止肾脏纤维化。
Abstract:  Objective: KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease state that: controlling blood sugar, lowering blood pressure, regulating blood lipids, anticoagulation, preventing renal fibrosis, controlling proteinuria, controlling protein intake, reducing weight and so on are effective ways for prevention and treatment of diabetes and DN. This study aims to reveal herbal administration regularity and mechanism of tonifying qi, nourishing yin and dissolving stasis method (TQNYDSM) for treating DN. Method: Based on KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease, we select literatures of DN treated by TQNYDSM, looking for herbal administration regularity and mechanism of TQNYDSM for Treating DN. Results and Conclusion: Deficiency of both qi and yin, renal blood stasis is the key pathogenesis of DN, TQNYDSM is the DN basic treatment method. Herbal Administration Regularity of TQNYDSM for Treating DN: try to add traditional Chinese medicine with effects on lowering blood sugar, blood pressure, regulating lipid, anticoagulation, against renal fibrosis into the prescription to protect renal function. Herbal mechanism of TQNYDSM for treating DN: hypoglycemic, antihypertensive, lipid-lowering, anticoagulation, preventing renal fibrosis.
文章引用:柯有甫, 曾乐谦, 高文谦, 魏克民, 郑军献. 益气养阴化瘀法治疗糖尿病肾病的用药策略[J]. 中医学, 2013, 2(4): 39-42. http://dx.doi.org/10.12677/TCM.2013.24010

参考文献

[1] National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. American Journal of Kidney Diseases, 2002, 39(5): S1-S266.
[2] National Kidney Foundation. KDOQI clinical practice guide- lines and clinical practice recommendations for diabetes and chronic kidney disease. American Journal of Kidney Diseases, 2007, 49(3): S1-S180.
[3] National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. American Journal of Kid- ney Diseases, 2012, 60(5): 850-886.
[4] Y. Slinin, A. Ishani, T. Rector, et al. Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and chronic kidney disease: A systematic review for a clinical practice guideline for the National Kidney Foundation. American Journal of Kidney Diseases, 2012, 60(5): 747-769.
[5] Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 2013, 3(1): 1-150.
[6] Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kid- ney International, 2012, 2: 337-414.
[7] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2010年版)[J]. 中国糖尿病杂志, 2012, 20(1): S1-S37.
[8] 郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 2002: 163-168.
[9] 中华中医药学会. 糖尿病中医防治指南[M]. 北京: 中国中医药出版社, 2007: 14-19.
[10] 中华中医药学会肾病分会. 糖尿病肾病诊断、辨证分型及疗效评定标准[J]. 上海中医药杂志, 2007, 41(7): 7-8.
[11] 黄佳娜. 糖尿病从气阴两虚论治的理论探讨[J]. 中国中医基础医学杂志, 2000, 6(9): 561-562.
[12] 张清梅, 陈泽奇, 刘英哲等. 1490例2型糖尿病临床辨证分型调查分析[J]. 湖南中医学院学报, 2004, 24(5): 33-37.
[13] 柯有甫. 中医药防治糖尿病合并高血压[J]. 中医临床研究, 2011, 3(21): 14.
[14] 柯有甫. 中医药防治肾性高血压[J]. 中国医药指南, 2011, 9 (22): 323.
[15] 柯有甫, 郑军献. 魔芋葡甘露聚糖治疗2型糖尿病初步临床观察[J]. 中医临床研究, 2012, 4(18): 61-62.
[16] 张丽芬, 吕仁和, 赵进喜等. 中医辨证治疗方案对糖尿病肾病肾功能不全患者生存质量的影响——多中心临床研究[J]. 中医杂志, 2008, 49(2): 119-122.
[17] 李青, 张惠敏, 费宇彤等. 中西医结合治疗糖尿病肾病多中心前瞻性队列研究[J]. 中国中西医结合杂志, 2012, 32(3): 317- 321.